FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023586013> ?p ?o ?g. }

• W2023586013 endingPage "33" @default.
• W2023586013 startingPage "27" @default.
• W2023586013 abstract "In this work, the effect of 10% of dimethylsulfoxide (DMSO), 1-[2-(decylthio)ethyl]azacyclopentan-2-one (HPE-101) and Labrafac®CC (a mixture of caprylic and capric acid triglycerides) on porphyrin formation in mouse skin during topical application of methyl 5-aminolevulinate (MAL) was studied. The porphyrin level in mouse skin was determined by measuring directly fluorescence and by extraction method. The porphyrin fluorescence kinetics during continuous application of MAL in creams in concentrations 2, 10 and 20% (wt./wt.) for up to 7 h showed that in this concentration range the kinetics of porphyrin production in the site of application does not depend significantly on the MAL concentration. After 24 h of application of all studied creams the porphyrin fluorescence in the area of treatment was dramatically reduced to be about two-fold higher than the skin autofluorescence, suggesting a significant decrease of the porphyrin concentration in these sites, although in all cases traces of porphyrins were found. It was found by extraction method that a 10% MAL cream with 10% DMSO for 4 h increased the concentration of porphyrin about four-fold compared with 10% MAL cream alone. The presence of 10% HPE-101 or 10% Labrafac®CC in the 10% MAL cream increased the porphyrin concentration in the area of application about 2.5- and 2-fold, respectively, as compared with MAL cream without enhancers. No statistically significant difference was found between the effects of the creams containing 10% MAL with 10% HPE-101 or 10% Labrafac®CC. The results obtained after 24 h of mouse skin treatment with the same creams showed a large decrease of porphyrin formation in comparison with results found after 4 h. All porphyrin concentrations measured after this time of MAL creams application were similar. Skin erythema was observed using MAL cream with DMSO and HPE-101, but not with Labrafac®CC. Our work suggests that the new penetration enhancer Labrafac®CC in creams with MAL may be used to increase the penetration of MAL through the mouse skin and at the same time increase production of porphyrin in the skin. This may reduce skin erythema, which is induced by DMSO and HPE-101." @default.
• W2023586013 created "2016-06-24" @default.
• W2023586013 creator A5008626914 @default.
• W2023586013 creator A5018135780 @default.
• W2023586013 creator A5023483696 @default.
• W2023586013 creator A5060453194 @default.
• W2023586013 creator A5062103496 @default.
• W2023586013 creator A5089578099 @default.
• W2023586013 date "2006-03-01" @default.
• W2023586013 modified "2023-10-16" @default.
• W2023586013 title "The effect of dimethylsulfoxide, 1-[2-(decylthio)ethyl]azacyclopentan-2-one and Labrafac®CC on porphyrin formation in normal mouse skin during topical application of methyl 5-aminolevulinate: A fluorescence and extraction study" @default.
• W2023586013 cites W1506108633 @default.
• W2023586013 cites W1515777772 @default.
• W2023586013 cites W1965996265 @default.
• W2023586013 cites W1966580456 @default.
• W2023586013 cites W1974008347 @default.
• W2023586013 cites W1975134203 @default.
• W2023586013 cites W1975136860 @default.
• W2023586013 cites W2025011011 @default.
• W2023586013 cites W2028012228 @default.
• W2023586013 cites W2033610485 @default.
• W2023586013 cites W2033659449 @default.
• W2023586013 cites W2035646278 @default.
• W2023586013 cites W2036068128 @default.
• W2023586013 cites W203657786 @default.
• W2023586013 cites W2045956856 @default.
• W2023586013 cites W2046897703 @default.
• W2023586013 cites W2052821687 @default.
• W2023586013 cites W2053912922 @default.
• W2023586013 cites W2057917620 @default.
• W2023586013 cites W2062704583 @default.
• W2023586013 cites W2071688519 @default.
• W2023586013 cites W2073028434 @default.
• W2023586013 cites W2076894165 @default.
• W2023586013 cites W2079353700 @default.
• W2023586013 cites W2090130916 @default.
• W2023586013 cites W2094659059 @default.
• W2023586013 cites W2098321566 @default.
• W2023586013 cites W2142724853 @default.
• W2023586013 cites W2144417922 @default.
• W2023586013 cites W2151481608 @default.
• W2023586013 cites W2575763377 @default.
• W2023586013 cites W4240821889 @default.
• W2023586013 cites W4250626137 @default.
• W2023586013 cites W4253817109 @default.
• W2023586013 doi "https://doi.org/10.1016/s1572-1000(05)00109-2" @default.
• W2023586013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25049025" @default.
• W2023586013 hasPublicationYear "2006" @default.
• W2023586013 type Work @default.
• W2023586013 sameAs 2023586013 @default.
• W2023586013 citedByCount "9" @default.
• W2023586013 countsByYear W20235860132014 @default.
• W2023586013 countsByYear W20235860132016 @default.
• W2023586013 countsByYear W20235860132021 @default.
• W2023586013 crossrefType "journal-article" @default.
• W2023586013 hasAuthorship W2023586013A5008626914 @default.
• W2023586013 hasAuthorship W2023586013A5018135780 @default.
• W2023586013 hasAuthorship W2023586013A5023483696 @default.
• W2023586013 hasAuthorship W2023586013A5060453194 @default.
• W2023586013 hasAuthorship W2023586013A5062103496 @default.
• W2023586013 hasAuthorship W2023586013A5089578099 @default.
• W2023586013 hasConcept C121332964 @default.
• W2023586013 hasConcept C13965031 @default.
• W2023586013 hasConcept C148898269 @default.
• W2023586013 hasConcept C185592680 @default.
• W2023586013 hasConcept C2779480358 @default.
• W2023586013 hasConcept C43617362 @default.
• W2023586013 hasConcept C4725764 @default.
• W2023586013 hasConcept C55493867 @default.
• W2023586013 hasConcept C62520636 @default.
• W2023586013 hasConcept C91881484 @default.
• W2023586013 hasConceptScore W2023586013C121332964 @default.
• W2023586013 hasConceptScore W2023586013C13965031 @default.
• W2023586013 hasConceptScore W2023586013C148898269 @default.
• W2023586013 hasConceptScore W2023586013C185592680 @default.
• W2023586013 hasConceptScore W2023586013C2779480358 @default.
• W2023586013 hasConceptScore W2023586013C43617362 @default.
• W2023586013 hasConceptScore W2023586013C4725764 @default.
• W2023586013 hasConceptScore W2023586013C55493867 @default.
• W2023586013 hasConceptScore W2023586013C62520636 @default.
• W2023586013 hasConceptScore W2023586013C91881484 @default.
• W2023586013 hasIssue "1" @default.
• W2023586013 hasLocation W20235860131 @default.
• W2023586013 hasLocation W20235860132 @default.
• W2023586013 hasOpenAccess W2023586013 @default.
• W2023586013 hasPrimaryLocation W20235860131 @default.
• W2023586013 hasRelatedWork W1673136237 @default.
• W2023586013 hasRelatedWork W1972599921 @default.
• W2023586013 hasRelatedWork W1978579181 @default.
• W2023586013 hasRelatedWork W2000201965 @default.
• W2023586013 hasRelatedWork W2066897436 @default.
• W2023586013 hasRelatedWork W2124866723 @default.
• W2023586013 hasRelatedWork W2144619095 @default.
• W2023586013 hasRelatedWork W2375476515 @default.
• W2023586013 hasRelatedWork W2949218384 @default.
• W2023586013 hasRelatedWork W48184077 @default.
• W2023586013 hasVolume "3" @default.
• W2023586013 isParatext "false" @default.

• next